Usefulness of contrast-enhanced ultrasonography in determining treatment efficacy and outcome after pancreatic cancer chemotherapy

doi:10.3748/wjg.14.7183

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 47

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2978)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-9) series, Tables (1-1) series.

Item

Count

PDF

270

HTML

2245

Figures (1-9)

253

Tables (1-1)

210

Sum=2978

Dec 21, 2008 (publication date) through Nov 4, 2024

Times Cited of This Article

Times Cited (17)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Research

World J Gastroenterol. Dec 21, 2008; 14(47): 7183-7191
Published online Dec 21, 2008. doi: 10.3748/wjg.14.7183

Full Size Figure Download Figure

Figure 4 CE-US changes over time in the R (II) group (luminance score). A: B-mode; B: Pre (0.96); C: Post 2 course (0.99); D: Post 4 course (1.0); E: Post 7 course (0.93); F: Post 11 course (1.0).

Citation: Sofuni A, Itoi T, Itokawa F, Tsuchiya T, Kurihara T, Ishii K, Tsuji S, Ikeuchi N, Moriyasu F. Usefulness of contrast-enhanced ultrasonography in determining treatment efficacy and outcome after pancreatic cancer chemotherapy. World J Gastroenterol 2008; 14(47): 7183-7191
URL: https://www.wjgnet.com/1007-9327/full/v14/i47/7183.htm
DOI: https://dx.doi.org/10.3748/wjg.14.7183